Effect of everolimus on the pharmacokinetics of octreotide long‐acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT‐2 trial

    loading  Checking for direct PDF access through Ovid

Excerpt

Related Topics

    loading  Loading Related Articles